S'abonner

Montelukast and Neuropsychiatric Events in Children with Asthma: A Nested Case–Control Study - 23/05/19

Doi : 10.1016/j.jpeds.2019.02.009 
S. Dresden Glockler-Lauf, MPH 1, Yaron Finkelstein, MD 1, 2, 3, 4, 5, Jingqin Zhu, MSc 1, 2, Laura Y. Feldman, MPH 1, Teresa To, PhD 1, 2, 6,
1 Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario 
2 Institute for Clinical Evaluative Sciences, Toronto, Ontario 
3 Division of Emergency Medicine, The Hospital for Sick Children, Toronto, Ontario 
4 Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Ontario 
5 Paediatrics, Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, Ontario 
6 Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario 

Reprint requests: Teresa To, PhD, Child Health Evaluative Sciences, The Hospital for Sick Children, 555 University Ave, Toronto, ON M5G 1X8.Child Health Evaluative SciencesThe Hospital for Sick Children555 University AveTorontoONM5G 1X8

Abstract

Objective

To examine the association between montelukast prescription and neuropsychiatric events in children with asthma.

Study design

A matched, nested case–control design was used to identify cases and controls from a cohort of children aged 5-18 years with physician-diagnosed asthma from 2004 to 2015, in Ontario, Canada, prescribed an asthma maintenance medication. Cases were children with a hospitalization or emergency department visit for a neuropsychiatric event. Cases were matched to up to 4 controls on birth year, year of asthma diagnosis, and sex. The exposures were dispensed prescriptions for montelukast (yes/no) and number of dispensed montelukast prescriptions in the year before the index date. Conditional logistic regression was used to measure the unadjusted OR and aOR and 95% CIs for montelukast prescription and neuropsychiatric events. Covariates in the adjusted model included sociodemographic factors and measures of asthma severity.

Results

In total, 898 cases with a neuropsychiatric event and 3497 matched controls were included. Children who experienced a new-onset neuropsychiatric event had nearly 2 times the odds of having been prescribed montelukast, compared with controls (OR 1.91, 95% CI 1.15-3.18; P = .01). Most cases presented for anxiety (48.6%) and/or sleep disturbance (26.1%).

Conclusions

Children with asthma who experienced a new-onset neuropsychiatric event had nearly twice the odds of having been prescribed montelukast in the year before their event. Clinicians should be aware of the association between montelukast and neuropsychiatric events in children with asthma, to inform prescribing practices and clinical follow-up.

Le texte complet de cet article est disponible en PDF.

Keywords : montelukast, asthma, neuropsychiatric events, drug safety, children

Abbreviations : ED, FDA, LHIN, LTRA, ODB, ON-Marg


Plan


 Supported by the SickKids Research Institute, Toronto, Ontario. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data and information compiled and provided by the Canadian Institute for Health Information (CIHI). However, the analyses, conclusions, opinions, and statements expressed herein are those of the author, and not necessarily those of CIHI. The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The authors declare no conflicts of interest.


© 2019  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 209

P. 176 - juin 2019 Retour au numéro
Article précédent Article précédent
  • Postconcussion Academic Support in Children Who Attend a Primary Care Provider Follow-up Visit after Presenting to the Emergency Department
  • Traci R. Snedden, Lauren A. Pierpoint, Dustin W. Currie, R. Dawn Comstock, Joseph A. Grubenhoff
| Article suivant Article suivant
  • Children's Oral Health and Academic Performance: Evidence of a Persisting Relationship Over the Last Decade in the United States
  • Carol Cristina Guarnizo-Herreño, Wei Lyu, George L. Wehby

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.